Humana (HUM) – StreetInsider.com Reports
-
Humana (HUM) PT Lowered to $370 at Oppenheimer
-
Humana (HUM) PT Lowered to $353 at RBC Capital
-
Humana (HUM) PT Lowered to $360 at Cantor Fitzgerald
-
Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
-
Insurer Humana pulls 2025 profit forecast on disappointing Medicare rates
-
Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
-
Humana (HUM) Tops Q1 EPS by 111c; reaffirms adjusted EPS outlook
-
Humana (HUM) April weekly option implied volatility into quarter results
-
Humana (HUM) and Cohere Health Expand Prior Authorization Partnership
-
Humana (HUM) PT Lowered to $381 at Jefferies
-
Humana (HUM) Declares $0.885 Quarterly Dividend; 1.1% Yield
-
Centene (CNC) stock higher after retaining Florida Medicaid contract
-
TD Cowen analyst comments after Florida releases its statewide Medicaid award
-
Centene (CNC) Gains After Retaining Florida Medicaid Contract, Molina Healthcare (MOH) Declines
-
Humana (HUM) PT Lowered to $355 at Truist Securities
-
Humana (HUM) PT Lowered to $332 at JPMorgan
-
Humana (HUM) PT Raised to $326 at Barclays
-
Humana (HUM) PT Lowered to $385 at Goldman Sachs
-
Humana (HUM) PT Lowered to $350 at Wells Fargo
-
Humana (HUM) PT Lowered to $385 at Goldman Sachs
-
Humana (HUM) call put ratio 1.2 calls to 1 put as share price down 13.7%
-
Analyst downgrades Humana on unchanged Medicare Advantage rates, insurers slide
-
Humana (HUM) PT Lowered to $334 at UBS
-
BofA Securities Downgrades Humana (HUM) to Neutral, 'Rebasing expectations on deteriorating reimbursement'
-
Humana (HUM) call put ratio 5.6 calls to 1 put
-
Humana (HUM) PT Lowered to $310 at Barclays
-
Health insurance stocks fall after-hours on Medicare Advantage news
-
Raymond James Starts Humana (HUM) at Market Perform
-
Humana (HUM) Completes $2.25B Debt Offering
-
Argus Downgrades Humana (HUM) to Hold, 'headwinds to revenue and earnings growth'
-
Humana (HUM) Prices $2.25 Billion Debt Offering
-
Humana (HUM) Files Mixed Shelf
-
Humana (HUM) Files Mixed Shelf
-
Barclays Starts Humana (HUM) at Equalweight
-
Alpine Immune Sciences (ALPN), Corteva (CTVA) and CVS Health (CVS) Added to Wolfe Alpha List
-
Humana (HUM) Declares $0.885 Quarterly Dividend; 1% Yield
-
Humana (HUM) PT Lowered to $425 at Wolfe Research
-
Humana (HUM) PT Lowered to $413 at Wells Fargo
-
Humana (HUM) PT Lowered to $427 at TD Cowen
-
Humana (HUM) PT Lowered to $450 at Goldman Sachs
-
Cantor Fitzgerald Downgrades Humana (HUM) to Neutral
-
Humana (HUM) PT Lowered to $400 at Truist Securities
-
UBS Downgrades Humana (HUM) to Neutral
-
Humana (HUM) PT Lowered to $415 at Oppenheimer
-
Humana (HUM) PT Lowered to $430 at Stephens
-
Humana (HUM) PT Lowered to $415 at RBC Capital
-
Humana (HUM) PT Lowered to $400 at Mizuho Securities
-
Humana (HUM) PT Lowered to $450 at Goldman Sachs
-
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.64%
-
Humana (HUM) call put ratio 1 call to 1.3 puts as share price down 11.4%
Back to HUM Stock Lookup